In the session, Mark Lesselroth, President of BioPortUSA, provided an in-depth perspective on what it takes for international medtech companies to successfully enter and grow in the U.S. market.
Mr. Lesselroth addressed common pitfalls foreign firms encounter, the critical importance of comprehensive market research and real-world validation, and the ways in which pricing strategies influence market adoption. He will also highlight the essential role of local expertise in navigating regulatory requirements, establishing credibility, and building the foundation for long-term success in one of the world’s most competitive healthcare markets.
Related Post
Latest Articles
Sep 9, 2025, 4:54 PM
Apr 29, 2025, 10:33 AM
Apr 22, 2025, 12:21 PM